Allergan, Merz's $54.4M Nameda Pay-For-Delay Deal Wins OK

By Hailey Konnath (November 14, 2022, 8:27 PM EST) -- A New York federal judge on Monday granted preliminary approval to consumers' $54.4 million settlement with pharmaceutical companies Allergan and Merz over alleged pay-for-delay deals that kept generic versions of the Alzheimer's disease drug Namenda off the market, an agreement reached on the eve of trial....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!